Commentary on the new 2022 European Society of Human Reproduction and Embryology (ESHRE) endometriosis guidelines
- Author:
Eun Hee YU
1
;
Jong Kil JOO
Author Information
- Publication Type:Review Article
- From:Clinical and Experimental Reproductive Medicine 2022;49(4):219-224
- CountryRepublic of Korea
- Language:English
- Abstract: Endometriosis is a prevalent benign illness defined by the presence of endometrial glands and stroma outside of the uterine cavity, primarily on the ovary, pelvic peritoneum, and rectovaginal septum, resulting in a variety of symptoms, including dysmenorrhea and infertility. Traditionally, prolonged medical therapy has been needed in most cases since a conservative approach to surgery has usually been taken, especially in young women. In 2022, new European Society of Human Reproduction and Embryology (ESHRE) guidelines were published that present different directions for diagnosis and treatment from the past. Furthermore, the guidelines for the diagnosis and management of endometriosis are more precise and applicable than in previous editions. Thus, referring to the representative changes in the new guidelines and important updates will be beneficial for the diagnosis and management of endometriosis. This paper provides a brief overview of these developments.
